Our Bureau

Mumbai, March 16

Hikal Ltd has received the Certificate of Suitability (CoS) in Europe for Ondansetron Hydrochloride Dihydrate, used to prevent vomiting during surgery and in cancer-related treatments such as chemotherapy and radiotherapy. The European Directorate for the Quality of Medicines has certified the product after evaluating its dossiers, the company said in a statement. "We have filled 3 more products for CoS in Europe apart from Ondansetron. This certificate will enable us commercialise our product for European countries", said Mr Jai Hiremath, Vice-Chairman and Managing Director, Hikal Ltd.

(This article was published in the Business Line print edition dated March 17, 2006)
XThese are links to The Hindu Business Line suggested by Outbrain, which may or may not be relevant to the other content on this page. You can read Outbrain's privacy and cookie policy here.